课题基金 / 基金详情

Analysis of risk factors for gastric cancer in order to construct tailor-made medicine for gastric cancer

Analysis of risk factors for gastric cancer in order to construct tailor-made medicine for gastric cancer
分析胃癌危险因素构建胃癌个体化药物
批准号:
15390231
负责人:
AZUMA Takeshi
金额:
$7.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

AZUMA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
After attachment of cagA-positive H. pylori to gastric epithelial cells, CagA is directly injected from the bacteria into the cells via the bacterial type IV secretion system and undergoes tyrosine phosphorylation in the host cells. We recently discovered that translocated CagA forms a physical complex with SHP-2. SHP-2 is known to play an important positive role in mitogenic signal transduction. Deregulation of SHP-2 by CagA may induce abnormal proliferation of gastric epithelial cells. In addition, the CagA protein is polymorphic. We discovered that predominant CagA proteins isolated in East Asia, where gastric cancer is prevalent, have a distinct sequence at the phosphorylation site of CagA. East Asian-specific sequence confers stronger SHP-2 binding and transforming activities to Western CagA. The diversity of the CagA phosphorylation site, which collectively determines binding affinity of CagA to SHP-2, may be an important variable in determining the clinical outcome of infection. We examined the CagA diversity of H. pylori isolated from patients with chronic gastritis or gastric cancer in Japan. The prevalence of East Asian CagA was significantly higher in patients with gastric cancer than in patients with chronic gastritis. The risk for gastric cancer associated with East Asian CagA-positive H. pylori infection was 11.8 (95% confidence limits, 7.33 to 383.31). Endemic circulation of H. pylori populations with more virulent East Asian CagA proteins may affect the prevalence of gastric cancer.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Rare Helicobacter pylori infection as a factor for the very low stomach cancer incidence in Yogyakarta, Indonesia.
罕见的幽门螺杆菌感染是印度尼西亚日惹胃癌发病率极低的一个因素。
DOI: --
发表时间: 2005
期刊: Cancer Lett. 219
影响因子: --
作者: [Tokudome, S. et al.]
通讯作者: S. et al.
Azuma T: "Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer"J.Infect.Dis.. 89. 820-827 (2004)
Azuma T:“幽门螺杆菌 CagA 蛋白的含有 Src 同源性 2 结构域的酪氨酸磷酸酶结合位点的多样性与胃萎缩和癌症之间的关联”J.Infect.Dis.. 89. 820-827 (2004)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zhou W: "The diversity of vacA and cagA genes of Helicobacter pylori in East Asia"FEMS Immunol.Med.Microbiol. 40. 81-87 (2004)
周文:“东亚幽门螺杆菌vacA和cagA基因的多样性”FEMSImmunol.Med.Microbiol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gastric cancer cell line.
新建立的蒙古胃癌细胞系中幽门螺杆菌依赖性 NF-κ B 激活。
DOI: --
发表时间: 2005
期刊: Cancer Sci. 96
影响因子: --
作者: [Adachi K., Tsutsui H., 他, Nozaki K]
通讯作者: Nozaki K
10
    Medical application of atmospheric nonthermal plasmas.
    • 批准号:
      26670382
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      AZUMA Takeshi
    • 依托单位:
    Management of Helicobacter infection and its related gastrointestinal diseases in Asia
    • 批准号:
      25305027
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2013
    • 负责人:
      AZUMA Takeshi
    • 依托单位:
    Development of endoscopic treatment system using laser
    • 批准号:
      24659366
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      AZUMA Takeshi
    • 依托单位:
    Development of MR endoscopy
    • 批准号:
      22659146
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      AZUMA Takeshi
    • 依托单位:
    国内基金
    海外基金
    幽门螺杆菌感染者外泌体CagA通过血管平滑肌细胞在动脉粥样硬化中的作用机制研究
    • 批准号:
      2024Y9076
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      林爱萍
    • 依托单位:
    幽门螺杆菌激活“CagA-CDH3-Wnt/β-catenin”轴驱动胃黏膜肠化生的作用和机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2024
    • 负责人:
      滕永生
    • 依托单位:
    幽门螺杆菌毒力蛋白CagA通过调控核孔复合体的形成稳定ZEB1核内表达促进胃癌发生发展的机制研究
    CagA抑制端粒酶逆转录酶泛素化降解的分子机制及其在早期肠化生中的作用研究